After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
The wound care provider filed the suit for allegedly falsifying and misleading consumers with clinical data.
These stocks look ready to break out and trade higher from current levels.
Trade-Ideas LLC identified Osiris Therapeutics (OSIR) as a weak on high relative volume candidate
Cramer says Osiris Therapeutics is exciting, Opko Health is a buy and you can't go wrong with PPG Industries.
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.